Cite
Danhof M, de Boer A, Magnani HN, et al. Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis. 1992;22(2):73-84doi: 10.1159/000216298.
Danhof, M., de Boer, A., Magnani, H. N., & Stiekema, J. C. (1992). Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis, 22(2), 73-84. https://doi.org/10.1159/000216298
Danhof, M, et al. "Pharmacokinetic considerations on Orgaran (Org 10172) therapy." Haemostasis vol. 22,2 (1992): 73-84. doi: https://doi.org/10.1159/000216298
Danhof M, de Boer A, Magnani HN, Stiekema JC. Pharmacokinetic considerations on Orgaran (Org 10172) therapy. Haemostasis. 1992;22(2):73-84. doi: 10.1159/000216298. PMID: 1379967.
Copy
Download .nbib